Australian organisation announces licence and partnerships to investigate medicinal use of psychedelic drugs
Australia’s Commonwealth Scientific and Industrial Research Organisation has been issued a licence to conduct research into psychedelic drug treatments.
In an announcement on 18 May, CSIRO said it was moving into the research area to investigate the use of psychedelic drugs in treating mental illness. It said it would “work with local biomedical companies to extract, synthesise, improve and then develop manufacturing processes for up to 15 different psychedelic compounds”.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.